Marex Group plc Ordinary Shares
NASDAQ:MRXFinancial - Capital Markets
+$0.93 today
- Market cap
- $4.61B
- Beta
- -0.00
- P/E (TTM)
- 14.5
- EPS (TTM)
- $4.32
- Dividend yield
- 0.98%
Volume 0.83M
Average 1.11M
MRX Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Marex Group plc Ordinary SharesNASDAQ: MRX
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 44.3% from a year ago
Cash & equivalents stood at $3.85B at the end of Q2 FY2026, down 44.3% from a year earlier. Over 3 fiscal years it compounded at +91.4% a year.
Context
- Cash & equivalents amounted to 9.1% of total assets at the end of Q2 FY2026, down 13.0 pp from a year earlier.
- Cash & equivalents increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -44.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 6.38B USD
- Year-over-year change
- +149.5%
- 4-year CAGR
- +73.0%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.38B | +149.5% |
| FY2024 | 2024-12-31 | 2.56B | +72.3% |
| FY2023 | 2023-12-31 | 1.48B | +63.0% |
| FY2022 | 2022-12-31 | 910.1M | +27.8% |
| FY2021 | 2021-12-31 | 712M | — |
Cash & Equivalents vs competitors
How MRX compares with its peers on the latest reported figures
- MRX's Jun 2026 cash & equivalents of $3.85B is the 2nd highest of the 10 companies compared; the peer median is $822.06M.
- Its year-over-year change of -44.3% is the 8th highest of 10, against a peer median of -0.4%.
- Cash & equivalents amounts to 9.1% of total assets for MRX, versus a peer median of 4.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $177B | +4.7% | -12.1% | 8.1% | |
MRXMarex Group plc Ordinary Shares | Jun 2026 | $3.85B | -44.3% | +91.4% | 9.1% |
| Jun 2026 | $2.19B | +67.1% | +13.1% | 4.1% | |
| Jun 2026 | $2.19B | -0.4% | +1.2% | 4.9% | |
| Jun 2026 | $2.06B | +26.2% | +18.3% | 24.9% | |
| Sep 2026 | $822.06M | +6.1% | +21.7% | 14.3% | |
| Sep 2026 | $381.05M | -19.5% | +6.5% | 16.7% | |
| Sep 2026 | $365M | -22.3% | +17.5% | 1.3% | |
| Aug 2026 | $16.88M | -99.9% | +13.1% | 0.0% | |
| Sep 2026 | $0 | -100.0% | +6.4% | 0.0% | |
| Peer median (excluding MRX) | $822.06M | -0.4% | +13.1% | 4.9% | |
Competitors are the stored peer set for MRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 712M | 910.1M | 1.48B | 2.56B | 6.38B |
| Short-term Investments | 46.3M | 2.31B | 3.25B | 2.66B | 7.08B |
| Net Receivables | 2.17B | 9.04B | 7.71B | 9.55B | 11.07B |
| Inventory | 80.1M | 35.8M | 163.4M | 35.8M | 0 |
| Other Current Assets | 1.11B | 2.69B | 4.05B | 8.52B | 0 |
| Total Current Assets | 4.12B | 15.35B | 16.94B | 23.83B | 24.53B |
| Property, Plant & Equipment (Net) | 20.9M | 45.5M | 57.2M | 80.7M | 110.9M |
| Goodwill | 208.9M | 155.5M | 163.6M | 176.5M | 237.4M |
| Intangible Assets | 21.5M | 25.6M | 56M | 56.5M | 98M |
| Long-term Investments | 84.8M | 22M | 77M | 77.5M | 5.89B |
| Tax Assets | 4M | 7.6M | 21.4M | 46.7M | 30.6M |
| Other Non-current Assets | 799.7M | 133.5M | 300.4M | 46.1M | 3.78B |
| Total Non-current Assets | 1.14B | 389.7M | 675.6M | 484M | 10.15B |
| Total Assets | 5.26B | 15.74B | 17.61B | 24.31B | 34.68B |
| Account Payables | 3.29B | 6.65B | 4.92B | 7.74B | 11.78B |
| Short-term Debt | 1.13B | 5.22B | 4.43B | 4.58B | 7.81B |
| Tax Payables | 2.1M | 8.9M | 18M | 51.8M | 0 |
| Deferred Revenue | 0 | 1M | 500K | 2.4M | 0 |
| Other Current Liabilities | 200.3M | 2.42B | 4.65B | 7.41B | (12.96B) |
| Total Current Liabilities | 4.63B | 14.56B | 15.88B | 21.78B | 7.75B |
| Long-term Debt | 136.6M | 472.1M | 907.9M | 1.48B | 2.33B |
| Deferred Tax Liabilities | 3.2M | 100K | 3.7M | 4.5M | 14M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 23.23B |
| Total Non-current Liabilities | 156.8M | 504.3M | 951M | 1.56B | 25.66B |
| Total Liabilities | 4.79B | 15.07B | 16.84B | 23.34B | 33.41B |
| Common Stock | 100K | 100K | 100K | 100K | 100K |
| Retained Earnings | 346.6M | 455.3M | 555.3M | 722.4M | 982M |
| Accumulated OCI | (3.3M) | (1.7M) | (1.6M) | (22.6M) | 15.4M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | (200K) |
| Total Equity | 477.7M | 677.7M | 775.9M | 976.9M | 1.26B |
| Total Debt | 1.29B | 5.73B | 5.39B | 6.14B | 10.24B |
| Net Debt | 578.1M | 4.82B | 3.9B | 3.58B | 3.86B |
Marex Group plc Ordinary Shares
NASDAQ:MRX
Intrinsic Alpha fair value
Locked
Current Price
$64.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.